Default testing for COVID-19 in K-12 schools more effective than voluntary testing

by Phil Ciciora,University of Illinois at Urbana-ChampaignGraphical Abstract. Credit:iScience(2023). DOI: 10.1016/j.isci.2023.108770A new paper co-written by a team of University of

Updated on: March 20,2024 20

Default testing for COVID-19 in K-12 schools more effective than voluntary testing

by Phil Ciciora,University of Illinois at Urbana-ChampaignGraphical Abstract. Credit:iScience(2023). DOI: 10.1016/j.isci.2023.108770A new paper co-written by a team of University of

Updated on:March 20,2024 20

COVID-19: Anti-viral strategy with double effect

by Brigitte Holfelder,Max Planck SocietyThe protease PLpro of Sars-CoV-2 plays a central role in the viral life cycle. By cleaving also proteins of infected cells, PLpro interferes with the inna

Updated on: April 12,2024 17

COVID-19: Anti-viral strategy with double effect

by Brigitte Holfelder,Max Planck SocietyThe protease PLpro of Sars-CoV-2 plays a central role in the viral life cycle. By cleaving also proteins of infected cells, PLpro interferes with the inna

Updated on:April 12,2024 17

Stem cell study shows how gene activity modulates the amount of immune cell production in mice

byKeck School of Medicine of USCCredit: CC0 Public DomainAs people age or become ill, their immune systems can become exhausted and less capable of fighting off viruses such as the flu or COVID-

Updated on: April 22,2024 0

Stem cell study shows how gene activity modulates the amount of immune cell production in mice

byKeck School of Medicine of USCCredit: CC0 Public DomainAs people age or become ill, their immune systems can become exhausted and less capable of fighting off viruses such as the flu or COVID-

Updated on:April 22,2024 0

Effectiveness of COVID vaccines unclear for people with immune deficiencies—but they're safe and worthwhile

by Vanessa Bryant and Charlotte Slade,The ConversationCredit: AI-generated imageThe COVID vaccine rollout is underway in Australia, with people inphase 1bnow eligible to be vaccinate

Updated on: April 12,2024 18

Effectiveness of COVID vaccines unclear for people with immune deficiencies—but they're safe and worthwhile

by Vanessa Bryant and Charlotte Slade,The ConversationCredit: AI-generated imageThe COVID vaccine rollout is underway in Australia, with people inphase 1bnow eligible to be vaccinate

Updated on:April 12,2024 18

MS patients face much greater risk of hospitalization, death from COVID-19, despite high rates of vaccination

by European Society of Clinical Microbiology and Infectious DiseasesCredit: Pixabay/CC0 Public DomainNew real-world research being presented at this year's European Congress of Clinical Microbiolo

Updated on: April 30,2024 0

MS patients face much greater risk of hospitalization, death from COVID-19, despite high rates of vaccination

by European Society of Clinical Microbiology and Infectious DiseasesCredit: Pixabay/CC0 Public DomainNew real-world research being presented at this year's European Congress of Clinical Microbiolo

Updated on:April 30,2024 0

A vaccine against chronic inflammatory diseases

by Institut National de la Sante et de la Recherche MedicaleCredit: CC0 Public DomainIn animals, a vaccine modifying the composition and function of the gut microbiota provides protection against

Updated on: April 01,2024 13

A vaccine against chronic inflammatory diseases

by Institut National de la Sante et de la Recherche MedicaleCredit: CC0 Public DomainIn animals, a vaccine modifying the composition and function of the gut microbiota provides protection against

Updated on:April 01,2024 13

Long-acting injectable ART superior to standard care for poorly adherent people with HIV

by Elana GotkineFor people with HIV (PWH) and a history of suboptimal adherence to antiretroviral therapy, long-acting injectable treatment with cabotegravir and rilpivirine (LAI) is superior to oral

Updated on: March 20,2024 13

Long-acting injectable ART superior to standard care for poorly adherent people with HIV

by Elana GotkineFor people with HIV (PWH) and a history of suboptimal adherence to antiretroviral therapy, long-acting injectable treatment with cabotegravir and rilpivirine (LAI) is superior to oral

Updated on:March 20,2024 13

Study finds mpox DNA can persist in the body for up to four weeks

by Betty Zou,University of TorontoMpox E9L computed tomography values by time since symptom onset among 64 men with mpox infection for 7 specimen types: (A) nasopharyngeal swabs, (B) throat swab

Updated on: March 20,2024 17

Study finds mpox DNA can persist in the body for up to four weeks

by Betty Zou,University of TorontoMpox E9L computed tomography values by time since symptom onset among 64 men with mpox infection for 7 specimen types: (A) nasopharyngeal swabs, (B) throat swab

Updated on:March 20,2024 17

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed

Updated on: April 12,2024 10

T-cell abnormalities in severe COVID-19 cases

by Kumamoto UniversityA major difference between mild and severe cases of COVID-19 may be the extreme activation of T cells as they react to the virus. In mild cases, T cell activation is slowed

Updated on:April 12,2024 10

Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies

by University of Washington School of MedicineVaccine GPB510 is a tiny ball of protein studded with 60 copies of the SARS-CoV-2 Spike protein receptor-binding domain (red). Credit: Ian Haydon / U

Updated on: April 02,2024 16

Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies

by University of Washington School of MedicineVaccine GPB510 is a tiny ball of protein studded with 60 copies of the SARS-CoV-2 Spike protein receptor-binding domain (red). Credit: Ian Haydon / U

Updated on:April 02,2024 16

Fibrinolytic biomarkers for identifying patients at risk of severe COVID-19

by Juntendo University Research Promotion CenterSignificant decreases in circulating uPA and uPA/PAI-1 complex levels may be a novel biomarker of COVID-19 severity. Credit: Dr. Koichi Hattori/Juntendo

Updated on: March 20,2024 11

Fibrinolytic biomarkers for identifying patients at risk of severe COVID-19

by Juntendo University Research Promotion CenterSignificant decreases in circulating uPA and uPA/PAI-1 complex levels may be a novel biomarker of COVID-19 severity. Credit: Dr. Koichi Hattori/Juntendo

Updated on:March 20,2024 11

Hyperbaric oxygen therapy tested for post-COVID conditions

FEBRUARY 21, 2024byKarolinska InstitutetAnder Kjellberg. Credit: Martin StenmarkHyperbaric oxygen therapy—giving patients 100% oxygen at a pressure corresponding to 10–20 meters below sea level—

Updated on: March 15,2024 7

Hyperbaric oxygen therapy tested for post-COVID conditions

FEBRUARY 21, 2024byKarolinska InstitutetAnder Kjellberg. Credit: Martin StenmarkHyperbaric oxygen therapy—giving patients 100% oxygen at a pressure corresponding to 10–20 meters below sea level—

Updated on:March 15,2024 7